Word: cautiously
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...number of prisoners being released from death row, is a big part of the reason for the decline in executions generally. "That's had a ripple effect," says Richard Dieter of the Death Penalty Information Center, a Washington-based advocacy group. "The whole legal system has become more cautious about the death penalty. Prosecutors are not seeking it as much. Juries are returning more life sentences. And judges are granting more stays of execution. Last year there were over...
...them different in some ways from their embryonic counterparts. In mice, embryonic stem cells can generate a new mouse clone; iPS cells from the animals have so far stopped short of the same feat, aborting in midgestation, suggesting that some development cues may be missing. "It certainly makes me cautious," says Eggan...
...hope - a cautious hope - is that Agriprocessors, which went bankrupt in November, will soon be sold. An Israeli firm, Soglowek Nahariya Ltd., made a $40 million offer this month to buy Agriprocessors and a smaller subsidiary plant in Nebraska. "A sale is likely," says Joseph Sarachek, a court-appointed trustee temporarily overseeing Agriprocessors' operations. "This is a real buyer." But he adds that the offer is the opening bid in what will probably be a March auction for the plant, which was once the nation's largest kosher meat producer and once Postville's major employer, with 968 workers...
...Fairgrade is "cautiously optimistic," says the group's president, Megan McLaughlin, a former Georgetown University admissions officer whose three sons are ages 8, 11 and 13. Her husband is a Fairfax County high school grad, and McLaughlin says her in-laws recall fighting the current grading system before it was implemented in 1981. McLaughlin and others are cautious because the details of the new grading system still need to be ironed...
...that process wasn't such an easy hurdle to overcome. Because no one has used embryonic stem cells or the cells derived from them in people before, the FDA was particularly cautious. The trial that it approved is what's known as a Phase 1. It will involve no more than a dozen patients and is not designed to test the effectiveness of the cells. Rather, it will simply monitor the safety of inserting them into people. The researchers will be looking for whether the cells cause tumors, trigger an immune response or start to migrate away from the spinal...